Lowenthal Richard E
Insider CIK 1378550 · SPRY President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 875,000 | — | $0 | 875,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 50,000 | $14.49 | $724.5K | 1,196,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 767,600 | — | $0 | 767,600 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 261,900 | — | $0 | 261,900 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,297,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-17 | 2024-12-19 | 50,000 | $11.67 | $583.5K | 1,098,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.17 | $658.5K | 1,246,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $13.16 | $658.0K | 1,148,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 1,088,124 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-06 | 2024-12-09 | 13,789 | — | $0 | 20,684 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-06 | 2024-12-09 | 11,876 | — | $0 | 338,124 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 3,433,512 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-06 | 2024-12-09 | 13,789 | $1.44 | $19.9K | 3,421,636 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-06 | 2024-12-09 | 11,876 | $8.42 | $100.0K | 4,327,189 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,198,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-19 | 2024-11-21 | 50,000 | $13.95 | $697.5K | 1,347,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 4,876 | $17.64 | $86.0K | 1,248,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 45,124 | $16.76 | $756.3K | 1,253,375 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 4,955 | $17.64 | $87.4K | 1,296,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 45,045 | $16.76 | $755.0K | 1,301,449 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-15 | 2024-10-17 | 48,550 | $14.86 | $721.5K | 1,398,897 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-15 | 2024-10-17 | 50,000 | $14.88 | $744.0K | 1,298,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-15 | 2024-10-17 | 1,450 | $15.25 | $22.1K | 1,397,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,348,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 50,000 | $13.83 | $691.5K | 1,346,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,398,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-09-17 | 2024-09-19 | 50,000 | $12.93 | $646.5K | 1,447,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,448,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 50,000 | $11.50 | $575.0K | 1,396,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 2,300 | $16.26 | $37.4K | 1,497,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 11,523 | $15.62 | $180.0K | 1,500,760 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 36,216 | $14.76 | $534.5K | 1,512,283 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 2,261 | $16.25 | $36.7K | 1,498,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 11,756 | $15.61 | $183.5K | 1,499,747 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 35,944 | $14.76 | $530.5K | 1,511,503 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 14,599 | $11.78 | $172.0K | 1,481,895 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 35,401 | $12.76 | $451.7K | 1,446,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 14,637 | $11.77 | $172.3K | 1,583,862 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 35,363 | $12.77 | $451.6K | 1,548,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,598,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-07-16 | 2024-07-18 | 50,000 | $11.40 | $570.0K | 1,547,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,496,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-07-09 | 2024-07-11 | 50,000 | $9.62 | $481.0K | 1,648,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-06-12 | 2024-06-13 | 47,834 | $9.15 | $437.7K | 1,546,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-06-12 | 2024-06-13 | 48,028 | $9.14 | $439.0K | 1,698,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 2,166 | $9.00 | $19.5K | 1,594,328 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 1,972 | $9.00 | $17.7K | 1,746,527 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-16 | 2024-05-16 | 44,350 | $9.06 | $401.8K | 1,748,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-16 | 2024-05-16 | 44,746 | $9.06 | $405.4K | 1,597,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-15 | 2024-05-16 | 2,766 | $9.04 | $25.0K | 1,792,849 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-15 | 2024-05-16 | 2,381 | $9.05 | $21.5K | 1,642,193 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-14 | 2024-05-16 | 2,884 | $9.01 | $26.0K | 1,795,615 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-14 | 2024-05-16 | 2,873 | $9.01 | $25.9K | 1,644,574 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-07 | 2024-05-09 | 50,000 | $9.34 | $467.0K | 1,798,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-05-07 | 2024-05-09 | 50,000 | $9.34 | $467.0K | 1,596,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-04-23 | 2024-04-24 | 82,733 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-04-23 | 2024-04-24 | 48,260 | — | $0 | 34,473 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-04-23 | 2024-04-24 | 82,733 | $0.84 | $69.5K | 3,359,587 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-04-23 | 2024-04-24 | 48,260 | $1.44 | $69.5K | 3,407,847 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-04-19 | 2024-04-22 | 119,047 | — | $0 | 117,333 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-04-19 | 2024-04-22 | 69,444 | — | $0 | 166,936 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-04-19 | 2024-04-22 | 69,444 | $1.44 | $100.0K | 4,315,313 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-04-19 | 2024-04-22 | 119,047 | $0.84 | $100.0K | 4,245,869 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-04-16 | 2024-04-17 | 50,000 | $9.28 | $464.0K | 1,647,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-04-16 | 2024-04-17 | 50,000 | $9.28 | $464.0K | 1,848,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-04-09 | 2024-04-10 | 50,000 | $9.28 | $464.0K | 1,898,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-04-09 | 2024-04-10 | 50,000 | $9.28 | $464.0K | 1,646,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-25 | 2024-03-26 | 47,635 | $9.12 | $434.4K | 1,697,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-25 | 2024-03-26 | 47,632 | $9.12 | $434.4K | 1,948,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-22 | 2024-03-26 | 1,326 | $9.01 | $11.9K | 1,996,131 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-22 | 2024-03-26 | 1,017 | $9.03 | $9.2K | 1,745,082 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-21 | 2024-03-21 | 100 | $9.00 | $900 | 1,997,457 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-21 | 2024-03-21 | 372 | $9.00 | $3.3K | 1,746,099 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-19 | 2024-03-21 | 942 | $9.04 | $8.5K | 1,997,557 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-19 | 2024-03-21 | 976 | $9.03 | $8.8K | 1,746,471 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 48,295 | $9.14 | $441.4K | 1,696,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 48,461 | $9.14 | $442.9K | 1,998,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 239 | $9.00 | $2.2K | 2,046,960 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 205 | $9.00 | $1.8K | 1,744,789 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 1,500 | $9.00 | $13.5K | 1,744,994 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 1,300 | $9.00 | $11.7K | 2,047,199 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 1,982 | $9.01 | $17.9K | 2,048,499 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 1,000 | $9.02 | $9.0K | 1,747,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 800 | $9.02 | $7.2K | 1,746,494 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 25,456 | $9.02 | $229.6K | 1,747,294 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 24,303 | $9.02 | $219.2K | 1,748,447 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 49,019 | $9.02 | $442.2K | 2,050,481 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 100 | $9.01 | $901 | 1,772,750 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 500 | $9.01 | $4.5K | 2,099,500 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 100 | $9.01 | $901 | 1,772,750 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 880,000 | — | $0 | 880,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | G Gift | 2023-05-17 | 2024-01-04 | 1,050,000 | — | $0 | 4,126,822 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | G Gift | 2023-05-17 | 2024-01-04 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | G Gift | 2023-05-17 | 2024-01-04 | 1,050,000 | — | $0 | 3,276,854 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | G Gift | 2023-05-17 | 2024-01-04 | 1,050,000 | — | $0 | 2,100,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 236,380 | — | $0 | 236,380 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 82,733 | — | $0 | 82,733 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 236,380 | — | $0 | 236,380 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 82,733 | — | $0 | 82,733 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award | 2022-11-08 | 2022-11-10 | 1,772,850 | — | $0 | 1,772,850 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award | 2022-11-08 | 2022-11-10 | 5,176,822 | — | $0 | 5,176,822 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award | 2022-11-08 | 2022-11-10 | 1,772,850 | — | $0 | 1,772,850 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award | 2022-11-08 | 2022-11-10 | 4,326,854 | — | $0 | 4,326,854 | SEC↗ |